Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report from Orexo AB’s annual general meeting

Uppsala, Sweden - April 21, 2022   Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 21 April 2022 resolved, in accordance with the nomination committee’s proposal, that the number of board members shall be eight with no deputy board members. James Noble, Staffan Lindstrand, Henrik Kjær Hansen, Fred Wilkinson, Mary Pat Christie and Charlotte Hansson were re-elected as ordinary board members. Christine Rankin and Michael J Matly were elected as new members of the board. James Noble was elected as chairman of the board. Ernst & Young

Resolutions at Sweco AB’s Annual General Meeting and board resolutions on repurchase and transfer of treasury shares

Sweco AB (publ) (“Sweco”) has today April 21, 2022, held its Annual General Meeting. The Annual General Meeting resolved in accordance with all the proposals put forward by the Board of Directors and the Nomination Committee. Board of Directors, discharge of liability, fees, dividend etc. The Annual General Meeting resolved, as proposed by the Nomination Committee, that the Board of Directors shall be comprised of seven (ordinary) Directors elected by the general meeting and that no Deputy Directors shall be appointed. The Annual General Meeting re-elected Åsa Bergman, Alf Göransson,

Read original

Communiqué from the Annual General Meeting 2022 of Cell Impact AB (publ)

The annual general meeting of Cell Impact AB (Nasdaq First North GM: CI B) was held on April 21, 2022.Adoption of the profit and loss account and balance sheet as well as profit allocation The annual general meeting approved the balance sheets and income statements included in the annual report for the financial year 2021 and resolved, in accordance with the proposal of the board of directors and the CEO, that available profits of SEK 410,629,859 should be carried forward. Board of directors and auditor The annual general meeting granted the directors of the board and the CEO

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.04.2022

Fiskars Corporation   Stock Exchange Release 21.04.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.04.2022   Date 21.04.2022  Exchange transaction Buy  Share class FSKRS  Amount  5,000  Average price/share 20.8965 EURHighest price/share 20.9500 EURLowest price/share 20.8000 EURTotal price 104,482.50 EUR        The shares held by Fiskars Corporation on 21.04.2022:   FSKRS 523 635       On

Faron Presents Results from Melanoma Cohort of MATINS Trial at 18[th] Congress of the European Association of Dermato-Oncology (EADO)

Faron Pharmaceuticals Ltd. (“Faron” or “Company”)   Faron Presents Results from Melanoma Cohort of MATINS Trial at 18th Congress of the European Association of Dermato-Oncology (EADO)   · Compelling 30% clinical benefit rate seen following treatment with bexmarilimab in heavily pre-treated, checkpoint inhibitor refractory patient population · Analysis estimates 100% overall survival at 12-months for patients who experienced clinical benefit following treatment with bexmarilimab · Biomarker analysis shows melanoma patients with low baseline levels of inflammatory

Stena Adactum AB has received necessary competition approval for the mandatory public cash offer to the shareholders of Svedbergs i Dalstorp AB and thereby declares the offer unconditional

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this

BE Group’s Annual General Meeting 2022

BE Group’s Annual General Meeting 2022 was held today, Thursday April 21, at Elite Hotel Savoy in Malmö. The following principal resolutions were passed. Adoption of the result and balance sheet and discharge from liabilityThe Annual General Meeting resolved to approve the adopted statement of income and the balance sheet and the consolidated statement of income and consolidated balance sheet. The Board of Directors and the CEO was discharged from liability for the time period to which the report relates. Appropriation of the company’s profitThe AGM resolved, in accordance with

Nel ASA: Annual General Meeting held in Nel ASA

(Oslo, 21 April 2022) The Annual general meeting of Nel ASA was held today. All proposals, except 10.2 and 11.1, set out in the notice to the general meeting were approved. As a result, the Board does not have authorization to issue shares in connection with options already issued that will vest during 2022. Any gains for the employee on such options exercised will therefore have to be settled by cash rather than through issuing shares. This could lead to a cash cost for Nel ASA up to about NOK 47 million in addition to employer taxes. Please find minutes from the annual general meeting

WithSecure™ and Cue Health® collaborate to strengthen the integrity of COVID-19 test results

Issue in test, authorized for use in the US, EU, Canada, India, and Singapore, could have allowed certain individuals with cyber security expertise to change test results.Helsinki, Finland – April 21, 2022: WithSecure ™ (formerly known as F-Secure Business), and healthcare technology company Cue Health, have worked together to address a security issue that WithSecure™ discovered in Cue’s COVID-19 test, which delivers the results of a nasal swab test via Bluetooth to a mobile device. The issue could have allowed a subset of users to change results within the

Bulletin from the Annual General Meeting of John Mattson Fastighetsföretagen AB (publ)

At the annual general meeting (the “AGM”) of John Mattson Fastighetsföretagen AB (publ) held on 21 April 2022, the annual accounts for 2021 were adopted and the board members and CEO were discharged from liability for the 2021 financial year.The AGM resolved not to distribute any dividend for the 2021 financial year and that the funds available for appropriation by the AGM, approximately SEK 1,625 million, be carried forward. The AGM resolved that the board shall comprise five ordinary board members until the close of the next AGM. Johan Ljungberg, Håkan Blixt, Ulrika Danielsson,

Kebni receives strategic order to complete SAAB NLAW IMU development at an accelerated pace and initiate preparation for series volume production, total order value 8.2 MSEK

KebNi AB (publ.) has received an order to finalize the Saab NLAW IMU development, and to do so at an accelerated pace, with a widened project scopeStockholm, 21 April 2022 – Today, Kebni announces a strategic 8.2 MSEK order from Saab regarding the tailored IMU that Kebni develops for Saab´s NLAW system. This new order covers all remaining stages of the development phase, and the initial preparation for series volume production. Upon request from Saab, Kebni has significantly compressed the timeline for the development and the production preparations, while safeguarding high risk and

Minutes of Annual General Meeting in Audientes A/S

Company announcement no. 07-2022April 21, 2022 On 21 April 2022, at 15:00 the annual general meeting was held in Audientes A/S (CVR-no. 36 04 76 31) at the Company’s address, Teknikerbyen 5, 2830 Virum.The Company’s chairman Povl-André Bendz opened the meeting and informed that according to the Articles of Association section 5.7 the Board of Directors appointed Advokat Bjarke Sanbeck as Chairman of the meeting.   Bjarke Sanbeck accepted the nomination and noted that with the accession of the General Assembly that the meeting was regularly constituted and convened and a quorum in

#22-137 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-136 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Company announcement

Business transacted at the extraordinary general meetingToday, April 21, 2022, SimCorp A/S held its extraordinary general meeting, at which the following was adopted:   · Amendment of Article 7 of the company's Articles of Association removing the address for the company’s share registrar. · Amendments of the company's Articles of Association to become gender neutral.   Copenhagen, April 21, 2022 SimCorp A/S On behalf of the board of directors   Enquiries regarding this announcement should be addressed to Christian Kromann, Chief Executive Officer, SimCorp A/

Clinical study investigating Alex Therapeutics’ and Vicore’s standalone digital therapy (DTx) treating anxiety in patients with idiopathic pulmonary fibrosis (IPF) has launched in the US

· The DTx, Almee[TM], under clinical study was built on Alex Therapeutics proprietary “Alex DTx Platform”[1] · First clinical study with a digital therapy (DTx) in patients with IPF to address the psychological symptom burden in this disease · First patient enrolled in US pilot phase leading up to US pivotal phase of the study · The DTx is developed by Alex Therapeutics in collaboration with Vicore Pharma (”Vicore). Vicore is responsible for the clinical validation and commercialisation of the DTx Stockholm, April 21, 2022 - Alex Therapeutics, a Digital Therpautics (DTx) Software

NOTICE TO ANNUAL GENERAL MEETING OF ENDOMINES AB (PUBL)

Endomines AB, pressmeddelande 21.04.2022 kl. 16:00 CEST This is an unofficial office translation of the Swedish original. In case of differences the Swedish version shall prevail. The shareholders of Endomines AB (publ), reg. no. 556694-2974, are hereby invited to the Annual General Meeting to be held on 24 May 2022. The Board of Directors has decided that the meeting will be carried out through postal voting only, pursuant to temporary legislation. It will not be possible for shareholders to attend the meeting in person or by proxy. Information on the resolutions passed by the Annual

MilDef's Annual Report for 2021 is published

MilDef's Annual Report for 2021 has been published and is now available on MilDef's website. On the website, a printed version of the Annual Report can be ordered, in Swedish and English.MilDef's Annual Report for 2021 contains for instance developed information about:  • MiDef's vision and business model • MilDef's role in digitizing defence capabilities • Strategy for increased value creation • MilDef's market landscape and growing market • Leadership and employeeship • MilDef’s sustainability work Change in comparison with previously submitted Year-end report 2021

New, profitable vertical created when British orthosis manufacturer Footlabs invests in Swedish 3D printer

– Wematter has won its first UK-based customer, and it is from a strategically most interesting segment indeed! The Wematter SLS 3D printer will soon be able to churn out dermatologically approved orthoses! Every human is unique. So are our bodies. That’s why 3D printing is perfect for the production of orthoses. These are structures that are placed on your body for structural support. Like plaster, only stronger, more flexible, better looking, lighter, and more comfortable. The fit is always perfect. The body part on which it is to be placed is scanned, and a unique,

Committees of Metso Outotec’s Board of Directors

Metso Outotec Corporation’s stock exchange release on April 21, 2022, at 16:20 p.m. EESTThe Board of Directors of Metso Outotec Corporation held its organizing meeting after the Annual General Meeting held earlier today. In the organizing meeting, the Board of Directors elected the members of the Audit & Risk Committee and the Remuneration & HR Committee from among its members. Arja Talma was appointed as Chair of the Audit & Risk Committee and Klaus Cawén, Terhi Koipijärvi, Ian W. Pearce and Emanuela Speranza as its members. Antti Mäkinen was appointed as Chair of the Remuneration

LKAB’s interim report for first quarter 2022 to be published on 28 April

LKAB’s interim report for the first quarter 2022 will be published on LKAB’s website at around 13.00 CEST on 28 April. The company’s Annual General Meeting will be held on the same day, along with related seminars.The report will be sent out as a press release and published at https://www.lkab.com/en/about-lkab/financial-information/financial-reports/.  LKAB’s President and CEO Jan Moström will be available for comments by phone. Calls may be booked through Niklas Johansson, Senior Vice President Communication and Climate, on +46 10 144 52 19 or Frida Dagertun, Investor Relations, on +46

Arctic Bioscience – Mandatory notification of trade

Vartdal Holding AS, a legal person closely associated with a person discharging managerial responsibilities in Arctic Bioscience, has today bought 25,000 shares in Arctic Bioscience at an average price of NOK 17,441 per share. Following the transaction, Vartdal Holding AS holds 1,027,755 shares in Arctic Bioscience.Vartdal Holding AS is owned 33,33 % by Future Invest AS, which again is owned 100 % by Jan Endre Vartdal, member of the Board of Directors in Arctic Bioscience. In total, all legal persons closely associated with Jan Endre Vartdal, holds 1,831,356 shares in Arctic Bioscience

World of Darkness Launches Unbound, an Initiative Allowing Independent Developers to Make Games in its Vampire: The Masquerade Story World

Launching under the Unbound initiative are six Vampire: The Masquerade games, all participants in the Vampire Game Jam, with submissions open to developers around the worldSTOCKHOLM – April 21, 2022 – World of Darkness, the transmedia entertainment brand behind celebrated fantasy horror properties including Vampire: The Masquerade, Werewolf: The Apocalypse, and more, announced Unbound, an initiative allowing independent developers to create video games set in Vampire: The Masquerade 5th Edition and generate revenue from their work. Launching alongside Unbound are six games from the hugely

There are no items matching the current filter
There are no more items matching the current filter
Back to top